Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
2 mg | In stock | $ 56.00 | |
5 mg | In stock | $ 88.00 | |
10 mg | In stock | $ 129.00 | |
25 mg | In stock | $ 233.00 | |
50 mg | In stock | $ 451.00 | |
100 mg | In stock | $ 663.00 | |
200 mg | In stock | $ 945.00 | |
500 mg | In stock | $ 1,390.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 88.00 |
Description | CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent. |
Molecular Weight | 437.93 |
Formula | C22H24ClN7O |
CAS No. | 1439934-41-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (125.59 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CTX-0294885 1439934-41-4 Others CTX 0294885 kinome profiling diabetes inhibit PKB CTX0294885 Inhibitor cancer Protein kinase B inflammation Akt inhibitor